Ready for tomorrow

Fast, insight-rich analysis of news that matters to you | long-reads that outlive the news cycle

Now Reading:

This one-shot drug cut bad cholesterol by 62%. Why doctors are watching closely
  • Small
  • Medium
  • Large

This one-shot drug cut bad cholesterol by 62%. Why doctors are watching closely

Image: AI

An experimental Eli Lilly gene-editing drug sharply lowers LDL cholesterol in an early trial, raising hopes of a one-time treatment for high-risk heart patients, but larger studies must still prove long-term safety

For millions of people at high risk of heart disease, keeping cholesterol under control remains a lifelong struggle. Now, a major medical breakthrough has raised hopes: a single infusion that permanently edits a liver gene and sharply lowers “bad” cholesterol for at least a year.

Read the full article

login now

Join us and get access to insightful, multimedia storytelling like you have never seen before.